<DOC>
	<DOC>NCT01529255</DOC>
	<brief_summary>- The purpose of this study is to to prove that the long-term efficacy of strategy of treatment adjustment at W24 according to virological response based on ROADMAP concept is better than standard of care strategy. - To evaluate the off-treatment durability of HBeAg seroconversion in patients who discontinued treatment due to sustained HBeAg seroconversion and HBV DNA&lt;300copies/ml with over 12 months consolidation treatment</brief_summary>
	<brief_title>EFFORT Extension Study</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis B</mesh_term>
	<mesh_term>Hepatitis B, Chronic</mesh_term>
	<mesh_term>Telbivudine</mesh_term>
	<criteria>Treated with telbivudine or combined with adefovir in EFFORT study Patients are willing to participate in the extension study Patients provide information consent form Adjustment of poor compliance by investigators</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>Chronic Hepatitis B</keyword>
	<keyword>Compensated Chronic hepatitis B</keyword>
</DOC>